Transplant Data

Sr. No Date Of Transplant UHID of Patient Organ (Liver Heart & Kidney) Living Donor / Deceased Donor (Cadaver) Outcome
Transplant Report of Kamalnayan Bajaj Hospitals 2021
Result of Authorization Committee & Competent Authority
SR. NO. DATE OF COMMITTEE MEETING TYPE OF COMMITTEE CODE NO. ASSIGNED TO THE CASE RESULT OF COMMITTEE MEETING
1 22.12.2020 COMPETENT AUTHORITY, KAMALNAYAN BAJAJ HOSPITAL, CHHATRAPATI SAMBHAJINAGAR MMRI/ADMIN/1050 DATED 22.12.2020
MMRI/ADMIN/1051 DATED 22.12.2020
MMRI/ADMIN/1052 DATED 22.12.2020
MMRI/ADMIN/1053 DATED 22.12.2020
APPROVED

POST-TRANSPLANT OUTCOME SUMMARY

SOLID ORGAN TRANSPLANT PROGRAMME

06 July 2026

This summary presents consolidated post-transplant outcomes for all solid-organ transplants performed at Kamalnayan Bajaj Hospital under the Zonal Transplant Coordination Centre, prepared in support of NOTTO transparency and public-reporting directives.

Data reflects 211 recipient records for procedures carried out between 07 January 2021 and 30 June 2026.

Cohort Snapshot

Recipients
  • Total Recipients 211
  • Male / Female 185 / 26
  • Mean Age 36.6 yr (8–66)
Organ Distribution
  • Kidney 204 (96.7%)
  • Liver 6 (2.8%)
  • Heart 1 (0.5%)
Donor Details
  • Living Donor 196 (92.9%)
  • Deceased Donor 15 (7.1%)
  • Paediatric (<18 yr) 7

Annual Volume

2021
30
2022
27
2023
40
2024
41
2025
49
2026
24
(To 29 Jun)

Survival Outcomes by Follow-up Window

Follow-up Window Alive Deaths With Outcome Survival
1 Month 203 5 208 97.6%
3 Months 191 7 198 96.5%
6 Months 173 12 185 93.5%
1 Year 144 15 159 90.6%
3 Years 35 8 43 81.4%
5 Years & Above 8 1 9 88.9%

Swipe to view full table

Note: Survival is expressed among recipients with a documented outcome at each follow-up window. Blank later-window entries predominantly reflect recipients who have not yet reached that follow-up milestone (administrative censoring) rather than missing follow-up. Actuarial (Kaplan–Meier) estimates have not been computed.

Key Observations

Twenty-three recipient deaths were recorded across all windows (22 kidney, 1 heart; no liver deaths).

Graft dysfunction was documented in 12 recipients, and 3 recipients were marked as lost to follow-up.

Early survival remains strong with 97.6% survival at one month and 90.6% survival at one year among recipients with recorded one-year data, consistent with a predominantly living-donor kidney transplant programme.

Committee Report

Download the official post-transplant outcome report (PDF).